Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE-AWARENESS
NCT07486336Not yet recruiting
- Sponsor
- Ospedali Galliera
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Ospedali Galliera. Primary endpoint: Number of patients effectively managed with neuraxial approach. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07486336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07486336.